Machine Learning-Guided Screening and Molecular Docking for Proposing Naturally Derived Drug Candidates Against MERS-CoV 3CL Protease
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26073047 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mebarka Ouassaf und 4 weiteren Autor:innen. Beteiligte Einrichtung: Group of Computational and Medicinal Chemistry, LMCE Laboratory, University of Biskra, Biskra 07000, Algeria. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Machine Learning, Antiviral Agents, Middle East Respiratory Syndrome Coronavirus. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In this study, we utilized machine learning techniques to identify potential inhibitors of the MERS-CoV 3CL protease. Among the models evaluated, the Random Forest (RF) algorithm exhibited the highest predictive performance, achieving an accuracy of 0.97, an ROC-AUC score of 0.98, and an F1-score of 0.98. Following model validation, we applied it to a dataset of 14,194 naturally occurring compounds from PubChem. The top-ranked compounds were subsequently subjected to molecular docking, which identified Perenniporide B, Phellifuropyranone A, and Terrestrol G as the most promising candidates, with binding energies of −9.17, −9.08, and −8.71 kcal/mol, respectively. These compounds formed strong interactions with key catalytic residues, suggesting significant inhibitory potential against the viral protease. Furthermore, molecular dynamics simulations confirmed their stability within the active site, reinforcing their viability as antiviral agents. This study demonstrates the effectiveness of integrating machine learning with molecular modeling to accelerate the discovery of therapeutic candidates against emerging viral threats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Group of Computational and Medicinal Chemistry, LMCE Laboratory, University of Biskra, Biskra 07000, Algeria.
- Inserm U1086 ANTICIPE (Interdisciplinary Research Unit for Cancer Prevention and Treatment), Normandie Univ, Université de Caen Normandie, 14076 Caen, France.
- Comprehensive Cancer Center François Baclesse, UNICANCER, 14076 Caen, France.
- Laboratory of Natural Products and Medicinal Chemistry (LNPMC), Department of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Thandalam, Chennai 602105…
- Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom 2520, South Africa.
- Unit of Scientific Research, Applied College, Qassim University, Buraydah 52571, Saudi Arabia.
ORCID-Profile: Mebarka Ouassaf, Radhia Mazri, Kannan R R Rengasamy, Bader Y Alhatlani
Zitieren
APA
Ouassaf, M., Mazri, R., Khan, S. U., Rengasamy, K. R. R., & Alhatlani, B. Y. (2025). Machine Learning-Guided Screening and Molecular Docking for Proposing Naturally Derived Drug Candidates Against MERS-CoV 3CL Protease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073047
Vancouver
Ouassaf M, Mazri R, Khan SU, Rengasamy KRR, Alhatlani BY. Machine Learning-Guided Screening and Molecular Docking for Proposing Naturally Derived Drug Candidates Against MERS-CoV 3CL Protease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073047
BibTeX
@article{Ouassaf2025,
author = {Ouassaf, Mebarka and Mazri, Radhia and Khan, Shafi Ullah and Rengasamy, Kannan R R and Alhatlani, Bader Y},
title = {Machine Learning-Guided Screening and Molecular Docking for Proposing Naturally Derived Drug Candidates Against MERS-CoV 3CL Protease},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26073047}
}
EUVIMED